Business Context and Reporting Period
Company: Alector, Inc. (ALEC)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Quarter ended June 30, 2026
Business Context: The filing serves as a notification of the Company's announcement of financial results for the second quarter of 2026. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K and does not contain specific financial data. The following metrics are not present in the source text:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Note: Specific values for these metrics are not provided in the filing text; they are referenced as being available in the attached press release (Exhibit 99.1).
Material Changes
The filing text does not provide specific data regarding material changes in financial performance or position compared to the prior comparable period. It only confirms that results for the quarter ended June 30, 2026, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) for the full announcement but does not include management commentary, forward-looking guidance, or specific risk factors within the text provided.
Legal Disclaimer: The filing explicitly states that information furnished in Item 2.02 and Item 9.01 (including the press release) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2026) for actual revenue, cash burn, and operational metrics.
- Verify the specific details of the "Results of Operations" as the 8-K text only references the announcement.
- Confirm the Company's cash runway and liquidity status from the detailed financial statements referenced in the press release.
- Check for any updates on clinical trial progress or pipeline milestones typically included in the full press release.